Drug design is a time-consuming and cumbersome process due to the vast search space of drug-like molecules and the difficulty of investigating atomic and electronic interactions. The present paper proposes a computational drug design workflow that combines artificial intelligence (AI) methods, i.e., an evolutionary algorithm and artificial neural network model, and molecular dynamics (MD) simulations to design and evaluate potential drug candidates. For the purpose of illustration, the proposed workflow was applied to design drug candidates against the main protease of severe acute respiratory syndrome coronavirus 2. From the ∼140,000 molecules designed using AI methods, MD analysis identified two molecules as potential drug candidates.
22 February 2021 in Journal of Chemical Information and Modeling
The Automated Ligand Searcher (ALISE) is designed as an automated computational drug discovery tool. To approximate the binding free energy of ligands to a receptor, ALISE includes a three-stage workflow, with each stage involving an increasingly sophisticated computational method: molecular docking, molecular dynamics, and free energy perturbation, respectively. To narrow the number of potential ligands, poorly performing ligands are gradually segregated out. The performance and usability of ALISE are benchmarked for a case study containing known active ligands and decoys for the HIV protease. The example illustrates that ALISE filters the decoys successfully and demonstrates that the automation, comprehensiveness, and user-friendliness of the software make it a valuable tool for improved and faster drug development workflows.
Artiklen introducerer, hvordan molekylær dynamik simuleringer gør det muligt at undersøge proteiners struktur og bevægelser på atomart niveau. Med udgangspunkt i biologiske proteiner beskrives både de fysiske principper bag simuleringerne og deres anvendelse inden for moderne sundhedsvidenskab. Artiklen viser desuden, hvordan avancerede beregningsmetoder og kunstig intelligens kan bidrage til forståelsen af sygdomsmekanismer og udviklingen af fremtidige behandlinger.